Julie McHugh Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Julie McHugh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Julie McHugh. Julie McHugh is Chief Operating Officer in ENDO HEALTH SOLUTIONS INC. ($ENDP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in AERIE PHARMACEUTICALS INC ($AERI) and Director in TREVENA INC ($TRVN) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and in Lantheus Holdings, Inc. ($LNTH) and Director in Lantheus Holdings, Inc. ($LNTH) and Director in Evelo Biosciences, Inc. ($EVLO).
Latest Insider Trading Transactions of Julie McHugh
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AERI, ENDP, CRXX, EVLO, IRWD, LNTH, TRVN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 8,513 | 0 | 31,570 | 23.1 K to 31.6 K (+36.92 %) |
Apr 22 2021 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 2,500 | 0 | 125,607 | 123.1 K to 125.6 K (+2.03 %) |
Apr 13 2021 | EVLO | Evelo Biosciences, ... | McHugh Julie | Director | Option Exercise | A | 10.04 | 31,380 | 315,055 | 31,380 | |
Apr 13 2021 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Sell | S | 21.22 | 2,800 | 59,416 | 23,057 | 25.9 K to 23.1 K (-10.83 %) |
Oct 05 2020 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 1,259 | 0 | 25,857 | 24.6 K to 25.9 K (+5.12 %) |
Oct 05 2020 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 1,259 | 0 | 25,857 | 24.6 K to 25.9 K (+5.12 %) |
Sep 09 2020 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 9.77 | 7,950 | 77,672 | 123,107 | 131.1 K to 123.1 K (-6.07 %) |
Aug 12 2020 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 749 | 0 | 24,598 | 23.8 K to 24.6 K (+3.14 %) |
Jun 29 2020 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 13.27 | 7,800 | 103,506 | 7,800 | |
Jun 29 2020 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,750 | 0 | 8,100 | 6.4 K to 8.1 K (+27.56 %) |
Jun 05 2020 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 21,720 | 0 | 131,057 | 109.3 K to 131.1 K (+19.87 %) |
May 15 2020 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 1.05 | 64,103 | 67,308 | 64,103 | |
Mar 05 2020 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 8,095 | 0 | 23,849 | 15.8 K to 23.8 K (+51.38 %) |
Mar 02 2020 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Sell | S | 15.86 | 1,756 | 27,845 | 15,754 | 17.5 K to 15.8 K (-10.03 %) |
Jun 07 2019 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 11.26 | 1,500 | 16,890 | 109,337 | 110.8 K to 109.3 K (-1.35 %) |
May 31 2019 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 22,706 | 0 | 110,837 | 88.1 K to 110.8 K (+25.76 %) |
May 23 2019 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 39.44 | 7,800 | 307,632 | 7,800 | |
May 23 2019 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,750 | 0 | 6,350 | 4.6 K to 6.4 K (+38.04 %) |
May 16 2019 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 1.34 | 30,000 | 40,200 | 30,000 | |
Mar 06 2019 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 14.38 | 1,500 | 21,570 | 88,131 | 89.6 K to 88.1 K (-1.67 %) |
Feb 28 2019 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 5,353 | 0 | 20,105 | 14.8 K to 20.1 K (+36.29 %) |
Dec 10 2018 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 12.46 | 1,500 | 18,690 | 89,631 | 91.1 K to 89.6 K (-1.65 %) |
Sep 07 2018 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 19.10 | 1,500 | 28,650 | 91,131 | 92.6 K to 91.1 K (-1.62 %) |
Jun 27 2018 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Sell | S | 14.72 | 4,560 | 67,123 | 14,752 | 19.3 K to 14.8 K (-23.61 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
Jun 07 2018 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 17.62 | 1,500 | 26,430 | 92,631 | 94.1 K to 92.6 K (-1.59 %) |
Jun 04 2018 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 16,223 | 0 | 94,131 | 77.9 K to 94.1 K (+20.82 %) |
May 17 2018 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 1.84 | 30,000 | 55,200 | 30,000 | |
Mar 07 2018 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 7,911 | 0 | 19,312 | 11.4 K to 19.3 K (+69.39 %) |
Mar 06 2018 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 14.06 | 1,500 | 21,090 | 77,908 | 79.4 K to 77.9 K (-1.89 %) |
Dec 06 2017 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 16.45 | 1,500 | 24,675 | 79,408 | 80.9 K to 79.4 K (-1.85 %) |
Sep 07 2017 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Sell | S | 16.16 | 1,500 | 24,240 | 80,908 | 82.4 K to 80.9 K (-1.82 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,150 | 0 | 2,850 | 1.7 K to 2.9 K (+67.65 %) |
Jun 06 2017 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 3.08 | 15,000 | 46,200 | 15,000 | |
Jun 02 2017 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 15,625 | 0 | 82,408 | 66.8 K to 82.4 K (+23.40 %) |
Mar 01 2017 | LNTH | Lantheus Holdings, ... | McHugh Julie | Director | Grant | A | 0.00 | 8,730 | 0 | 11,401 | 2.7 K to 11.4 K (+326.84 %) |
Jan 26 2017 | LNTH | Lantheus Holdings, ... | McHugh Julie | Grant | A | 0.00 | 2,671 | 0 | 2,671 | 0 to 2.7 K | |
Jun 09 2016 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 19.50 | 10,000 | 195,000 | 10,000 | |
Jun 09 2016 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,700 | 0 | 1,700 | 0 to 1.7 K |
Jun 03 2016 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 23,674 | 0 | 66,783 | 43.1 K to 66.8 K (+54.92 %) |
May 19 2016 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 6.98 | 15,000 | 104,700 | 15,000 | |
Jul 06 2015 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 17.18 | 25,000 | 429,500 | 25,000 | |
Jun 08 2015 | CRXX | EPIRUS Biopharmace ... | McHugh Julie | Director | Option Exercise | A | 6.39 | 9,000 | 57,510 | 9,000 | |
Jun 05 2015 | IRWD | IRONWOOD PHARMACEU ... | McHugh Julie | Director | Grant | A | 0.00 | 16,556 | 0 | 43,109 | 26.6 K to 43.1 K (+62.35 %) |
May 21 2015 | TRVN | TREVENA INC | McHugh Julie | Director | Option Exercise | A | 6.80 | 8,870 | 60,316 | 8,870 | |
Mar 19 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Option Exercise | M | 0.00 | 3,511 | 0 | 7,021 | |
Mar 19 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Payment of Exercise | F | 35.91 | 1,074 | 38,567 | 2,437 | 3.5 K to 2.4 K (-30.59 %) |
Mar 19 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Buy | M | 0.00 | 3,511 | 0 | 3,511 | 0 to 3.5 K |
Feb 24 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Option Exercise | A | 34.70 | 53,131 | 1,843,646 | 53,131 | |
Feb 24 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Payment of Exercise | F | 34.79 | 1,251 | 43,522 | 2,686 | 3.9 K to 2.7 K (-31.78 %) |
Feb 24 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Grant | A | 0.00 | 16,138 | 0 | 31,883 | 15.7 K to 31.9 K (+102.50 %) |
Feb 24 2012 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Grant | A | 0.00 | 16,138 | 0 | 27,946 | 11.8 K to 27.9 K (+136.67 %) |
Mar 17 2011 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Option Exercise | M | 0.00 | 3,511 | 0 | 10,532 | |
Mar 17 2011 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Buy | M | 0.00 | 3,511 | 0 | 3,511 | 0 to 3.5 K |
Feb 25 2011 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Option Exercise | A | 33.98 | 49,128 | 1,669,369 | 49,128 | |
Feb 25 2011 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Buy | M | 0.00 | 15,745 | 0 | 15,745 | 0 to 15.7 K |
Feb 25 2011 | ENDP | ENDO HEALTH SOLUTI ... | McHugh Julie | Chief Operating Off ... | Buy | M | 0.00 | 15,745 | 0 | 15,745 | 0 to 15.7 K |
Page: 1